Know Cancer

forgot password

A Randomized, Double Blind, Placebo-Controlled Phase III Study To Determine The Efficacy Of Sandostatin LAR® Depot (Octreotide Acetate) In Preventing Or Reducing The Severity Of Chemoradiation-Induced Diarrhea In Patients With Anal Or Rectal Cancer

Phase 3
18 Years
Not Enrolling
Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis

Thank you

Trial Information

A Randomized, Double Blind, Placebo-Controlled Phase III Study To Determine The Efficacy Of Sandostatin LAR® Depot (Octreotide Acetate) In Preventing Or Reducing The Severity Of Chemoradiation-Induced Diarrhea In Patients With Anal Or Rectal Cancer



- Determine the ability of octreotide to prevent the incidence of moderate, severe, or
life-threatening chemoradiotherapy-induced diarrhea (grades 2-4) in patients with anal
or rectal cancer.


- Compare the quality of life of patients treated with this drug vs placebo.

- Compare the number of hospitalizations and use of antidiarrheal agents (e.g., Imodium®)
related to diarrhea (or its complications) in patients treated with these drugs.

- Compare treatment delays and/or dose reductions (chemotherapy and radiotherapy) in
patients treated with these drugs.

OUTLINE: This is a double-blind, placebo-controlled, randomized, multicenter study. Patients
are stratified according to radiotherapy dose (< 50 Gy vs ≥ 50 Gy), chemotherapy dose (bolus
vs continuous), and gender. Patients are randomized to 1 of 2 treatment arms.

- Arm I: Patients receive octreotide* intramuscularly (IM) 4-7 days before the start of
chemoradiotherapy and on day 22 (± 3 days) during chemoradiotherapy.

- Arm II: Patients receive placebo* IM 4-7 days before the start of chemoradiotherapy and
on day 22 (± 3 days) during chemoradiotherapy.

NOTE: *Patients receive a total of 2 injections of octreotide or placebo

In both arms, treatment continues in the absence of unacceptable toxicity.

Quality of life is assessed at baseline, at the completion of chemoradiotherapy, and at 3,
6, 9, and 15 months from the start of chemoradiotherapy.

Patients are followed at 3, 6, 9, and 15 months from the start of chemoradiotherapy.

PROJECTED ACCRUAL: A total of 226 patients (113 per treatment arm) will be accrued for this
study within 2 years.

Inclusion Criteria


- Histologically confirmed primary anal or rectal cancer

- No metastasis beyond the pelvic regional nodes

- Must be scheduled to receive chemoradiotherapy



- 18 and over

Performance status

- Not specified

Life expectancy

- Not specified


- Not specified


- Liver function tests < 3 times upper limit of normal

- No prior hepatic disease


- Not specified


- No prior chronic or acute regional enteritis

- No malabsorption syndrome

- No prior inflammatory bowel disease that may exacerbate the radiotherapy toxicity

- No grade 2 or greater uncontrollable diarrhea at baseline

- No prior cholecystitis or gallstones, unless a cholecystectomy has been performed

- No prior incontinence of stool


- Not pregnant or nursing

- Negative pregnancy test

- Fertile patients must use effective contraception

- HIV negative

- No uncontrolled diabetes (e.g., fasting glucose > 250 mg/dL)

- No prior allergy or hypersensitivity to study drug or other related drug or compound

- No other medical condition or mental impairment that would preclude study treatment
and compliance


Biologic therapy

- Not specified


- See Disease Characteristics

- Prior chemotherapy allowed

Endocrine therapy

- At least 6 months since prior administration of any of the following:

- Glucocorticoid therapy

- Insulin sensitizers (e.g., metformin, pioglitazone, or rosiglitazone)

- Exogenous growth hormone therapy


- See Disease Characteristics

- No prior pelvic radiotherapy

- No prior intensity-modulated radiotherapy

- No concurrent radiotherapy for abdominal cancer

- No concurrent hyperfractionated, split-course, or intensity-modulated radiotherapy

- No brachytherapy prior to or after completion of all external beam radiotherapy


- No prior abdominal-perineal resection or other surgical procedure leaving the patient
without a functioning rectum

- No colostomy


- More than 30 days since other prior investigational drugs

- No prior octreotide for cancer therapy-related diarrhea

- No concurrent prophylactic antidiarrheal medication

Type of Study:


Study Design:

Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Supportive Care

Outcome Measure:

Prevention of the incidence of moderate, severe, or life-threatening diarrhea

Principal Investigator

Babu Zachariah, MD

Investigator Role:

Study Chair

Investigator Affiliation:

H. Lee Moffitt Cancer Center and Research Institute


United States: Federal Government

Study ID:




Start Date:

December 2003

Completion Date:

Related Keywords:

  • Anal Cancer
  • Colorectal Cancer
  • Drug/Agent Toxicity by Tissue/Organ
  • Radiation Enteritis
  • radiation enteritis
  • drug/agent toxicity by tissue/organ
  • stage I rectal cancer
  • stage II rectal cancer
  • stage III rectal cancer
  • stage IIIA anal cancer
  • stage IIIB anal cancer
  • recurrent anal cancer
  • stage I anal cancer
  • stage II anal cancer
  • recurrent rectal cancer
  • Anus Neoplasms
  • Rectal Neoplasms
  • Colorectal Neoplasms
  • Enteritis



Akron City HospitalAkron, Ohio  44304
Roswell Park Cancer InstituteBuffalo, New York  14263
Mayo Clinic Cancer CenterRochester, Minnesota  55905
Indiana University Cancer CenterIndianapolis, Indiana  46202-5265
Duke Comprehensive Cancer CenterDurham, North Carolina  27710
CCOP - Upstate CarolinaSpartanburg, South Carolina  29303
CCOP - Kansas CityKansas City, Missouri  64131
CCOP - Mount Sinai Medical CenterMiami Beach, Florida  33140
CCOP - North Shore University HospitalManhasset, New York  11030
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical CenterGrand Junction, Colorado  81502
CCOP - Michigan Cancer Research ConsortiumAnn Arbor, Michigan  48106
West Michigan Cancer CenterKalamazoo, Michigan  49007-3731
Sparrow Regional Cancer CenterLansing, Michigan  48912-1811
St. Rita's Medical CenterLima, Ohio  45801
Penn State Cancer Institute at Milton S. Hershey Medical CenterHershey, Pennsylvania  17033-0850
Sutter Health Western Division Cancer Research GroupGreenbrae, California  94904
CCOP - Bay Area Tumor InstituteOakland, California  94609-3305
Memorial Hospital Cancer CenterColorado Springs, Colorado  80909
Ball Memorial HospitalMuncie, Indiana  47303-3499
Cape Cod HospitalHyannis, Massachusetts  02601
CCOP - Cancer Research for the OzarksSpringfield, Missouri  65807
New York Methodist HospitalBrooklyn, New York  11215-3609
CCOP - ColumbusColumbus, Ohio  43206
Reading Hospital and Medical CenterReading, Pennsylvania  19612-6052
CCOP - MainLine HealthWynnewood, Pennsylvania  19096
CCOP - GreenvilleGreenville, South Carolina  29615
LDS HospitalSalt Lake City, Utah  84143
University of Miami Sylvester Comprehensive Cancer CenterMiami, Florida  33136
CCOP - Grand RapidsGrand Rapids, Michigan  49503
Siteman Cancer Center at Barnes-Jewish HospitalSaint Louis, Missouri  63110
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire  03756-0002
CCOP - Columbia River Oncology ProgramPortland, Oregon  97225
CCOP - Scott and White HospitalTemple, Texas  76508
Cleveland Clinic Taussig Cancer CenterCleveland, Ohio  44195
Utah Valley Regional Medical Center - ProvoProvo, Utah  84604
Foundation for Cancer Research and EducationPhoenix, Arizona  85013
Monmouth Medical CenterLong Branch, New Jersey  07740-6395
Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical CenterMilwaukee, Wisconsin  53201-2901
University of California Davis Cancer CenterSacramento, California  95817
Mobile Infirmary Medical CenterMobile, Alabama  36640-0460
Veterans Affairs Medical Center - Tampa (Haley)Tampa, Florida  33612
Markey Cancer Center at University of Kentucky Chandler Medical CenterLexington, Kentucky  40536-0084
Josephine Ford Cancer Center at Henry Ford HospitalDetroit, Michigan  48202
St. John's Regional Health CenterSpringfield, Missouri  65804
SUNY Downstate Medical CenterBrooklyn, New York  11203
Central Baptist HospitalLexington, Kentucky  40503
Trinity Cancer Care CenterMinot, North Dakota  58701
University of Florida Shands Cancer CenterGainesville, Florida  32610-0232
Baptist-South Miami Regional Cancer ProgramMiami, Florida  33176
St. Vincent Hospital Regional Cancer CenterGreen Bay, Wisconsin  54307-3508
Aultman Hospital Cancer Center at Aultman Health FoundationCanton, Ohio  44710-1799
Torrance Memorial Medical CenterTorrance, California  90505
Sibley Memorial HospitalWashington, District of Columbia  20016
Baptist Cancer Institute - JacksonvilleJacksonville, Florida  32207
William Beaumont Hospital - Royal Oak CampusRoyal Oak, Michigan  48073
McKay-Dee Hospital CenterOgden, Utah  84403
Utah Cancer Specialists at UCS Cancer CenterSalt Lake City, Utah  84106
St. Joseph Hospital Community Cancer CenterBellingham, Washington  98225
Greenebaum Cancer Center at University of Maryland Medical CenterBaltimore, Maryland  21201
Memorial Cancer Institute at Memorial Regional HospitalHollywood, Florida  33021
CCOP - Nevada Cancer Research FoundationLas Vegas, Nevada  89109-2306
Paoli Memorial HospitalPaoli, Pennsylvania  19301-1792
Hillcrest Cancer Center at Hillcrest HospitalMayfield Heights, Ohio  44124
University Medical Center of Southern NevadaLas Vegas, Nevada  89102
Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross HospitalFort Lauderdale, Florida  33308
Ella Milbank Foshay Cancer Center at Jupiter Medical CenterJupiter, Florida  33458
Ingalls Cancer Care Center at Ingalls Memorial HospitalHarvey, Illinois  60426
St. Joseph Mercy Cancer Center at St. Joseph Mercy HospitalAnn Arbor, Michigan  48106-0995
Fox Chase Cancer Center at St. Francis Medical CenterTrenton, New Jersey  08629
Iredell Memorial HospitalStatesville, North Carolina  28677
LaFortune Cancer Center at St. John Medical CenterTulsa, Oklahoma  74104
Legacy Mount Hood Medical CenterGresham, Oregon  97030
Providence Milwaukie HospitalMilwaukie, Oregon  97222
Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer CenterPortland, Oregon  97210
Providence Cancer Center at Providence Portland Medical CenterPortland, Oregon  97213-2967
Providence St. Vincent Medical CenterPortland, Oregon  97225
Legacy Meridian Park HospitalTualatin, Oregon  97062
Bryn Mawr HospitalBryn Mawr, Pennsylvania  19010
Delaware County Regional Cancer Center at Delaware County Memorial HospitalDrexel Hill, Pennsylvania  19026
Lankenau Cancer Center at Lankenau HospitalWynnewood, Pennsylvania  19096
Dixie Regional Medical Center - East CampusSaint George, Utah  84770
Southwest Washington Medical Center Cancer CenterVancouver, Washington  98668
North Star Lodge Cancer Center at Yakima Valley Memorial HospitalYakima, Washington  98902
California Cancer Center - Woodward Park OfficeFresno, California  93720
Leavey Cancer Center at Northridge Hospital Medical CenterNorthridge, California  91325
Pomona Valley Hospital Medical CenterPomona, California  91767
H. Lee Moffitt Cancer Center and Research Institute at University of South FloridaTampa, Florida  33612
Wendt Regional Cancer Center at Finley HospitalDubuque, Iowa  52001
Regional Cancer Center at Singing River HospitalPascagoula, Mississippi  39581
Washoe Cancer Services at Washoe Medical Center - RenoReno, Nevada  89502
South Jersey Healthcare Regional Cancer CenterMillville, New Jersey  08332
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - OxfordSalem, Ohio  44460
Cancer Treatment CenterWooster, Ohio  44691
Institute of Oncology at Vilnius UniversityPortland, Oregon  97227
Allegheny Cancer Center at Allegheny General HospitalPittsburgh, Pennsylvania  15212
Western Pennsylvania Cancer Institute at Western Pennsylvania HospitalPittsburgh, Pennsylvania  15224-1791
All Saints Cancer Center at All Saints HealthcareRacine, Wisconsin  53405
West Allis Memorial HospitalWest Allis, Wisconsin  53227
Methodist Cancer Center at Methodist Hospital - OmahaOmaha, Nebraska  68114
Enloe Cancer Center at Enloe Medical CenterChico, California  95926
Saint Agnes Medical CenterFresno, California  93720-3397
Cancer Care Consultants Medical Associates at Daniel Freeman Memorial HospitalInglewood, California  90301
Radiological Associates of Sacramento Medical Group, IncorporatedSacramento, California  95815
St. John's Cancer Center at St. John's Medical CenterAnderson, Indiana  46016
Long Island College HospitalBrooklyn, New York  11201
Mercy Cancer Institute at Mercy HospitalPittsburgh, Pennsylvania  15219
Lipson Cancer and Blood Center at Rochester General HospitalRochester, New York  14621
Community Regional Cancer Center at Community Medical CenterToms River, New Jersey  08755
Veterans Affairs Medical Center - IndianapolisIndianapolis, Indiana  46202
John B. Amos Community Cancer CenterColumbus, Georgia  31902
Cancer Institute of New Jersey at Cooper University Hospital - CamdenCamden, New Jersey  08103
Columbia St. Mary's Cancer CenterMilwaukee, Wisconsin  53211